SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-047745
Filing Date
2019-10-09
Accepted
2019-10-09 11:46:54
Documents
14
Period of Report
2019-10-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv530855_8k.htm   iXBRL 8-K 25638
2 EXHIBIT 99.1 tv530855_ex99-1.htm EX-99.1 13028
3 GRAPHIC image_001.jpg GRAPHIC 5964
  Complete submission text file 0001144204-19-047745.txt   224246

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA srne-20191009.xsd EX-101.SCH 3222
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20191009_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20191009_pre.xml EX-101.PRE 22734
14 EXTRACTED XBRL INSTANCE DOCUMENT tv530855_8k_htm.xml XML 3490
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 191144006
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services